These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1678520)

  • 41. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
    Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
    Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ATPase activity of nucleotide binding domains of human MDR3 in the context of MDR1.
    Ishigami M; Tominaga Y; Nagao K; Kimura Y; Matsuo M; Kioka N; Ueda K
    Biochim Biophys Acta; 2013 Apr; 1831(4):683-90. PubMed ID: 23305784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional expression of murine multidrug resistance in Xenopus laevis oocytes.
    Castillo G; Vera JC; Yang CP; Horwitz SB; Rosen OM
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4737-41. PubMed ID: 1693776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.
    Doige CA; Sharom FJ
    Biochim Biophys Acta; 1992 Aug; 1109(2):161-71. PubMed ID: 1355667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.
    Kohno K; Sato S; Takano H; Matsuo K; Kuwano M
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1415-21. PubMed ID: 2575381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.
    Kast C; Canfield V; Levenson R; Gros P
    Biochemistry; 1995 Apr; 34(13):4402-11. PubMed ID: 7535563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane.
    Loo TW; Clarke DM
    J Biol Chem; 1999 Dec; 274(50):35388-92. PubMed ID: 10585407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Co-amplification and over-expression of two mdr genes in a multidrug-resistant human colon carcinoma cell line.
    Chao CC; Ma CM; Lin-Chao S
    FEBS Lett; 1991 Oct; 291(2):214-8. PubMed ID: 1682162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
    Schinkel AH; Kemp S; Dollé M; Rudenko G; Wagenaar E
    J Biol Chem; 1993 Apr; 268(10):7474-81. PubMed ID: 8096511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene.
    Henderson DM; Sifri CD; Rodgers M; Wirth DF; Hendrickson N; Ullman B
    Mol Cell Biol; 1992 Jun; 12(6):2855-65. PubMed ID: 1350325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.
    Ueda K; Cardarelli C; Gottesman MM; Pastan I
    Proc Natl Acad Sci U S A; 1987 May; 84(9):3004-8. PubMed ID: 3472246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
    Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.
    Kioka N; Tsubota J; Kakehi Y; Komano T; Gottesman MM; Pastan I; Ueda K
    Biochem Biophys Res Commun; 1989 Jul; 162(1):224-31. PubMed ID: 2568832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional expression of mouse mdr1 in Escherichia coli.
    Bibi E; Gros P; Kaback HR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9209-13. PubMed ID: 8105473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure and expression of the human MDR (P-glycoprotein) gene family.
    Chin JE; Soffir R; Noonan KE; Choi K; Roninson IB
    Mol Cell Biol; 1989 Sep; 9(9):3808-20. PubMed ID: 2571078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational analysis of P-glycoprotein in yeast Saccharomyces cerevisiae.
    Beaudet L; Gros P
    Methods Enzymol; 1998; 292():414-27. PubMed ID: 9711571
    [No Abstract]   [Full Text] [Related]  

  • 58. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
    Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Domain exchangeability between the multidrug transporter (MDR1) and phosphatidylcholine flippase (MDR2).
    Zhou Y; Gottesman MM; Pastan I
    Mol Pharmacol; 1999 Nov; 56(5):997-1004. PubMed ID: 10531406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site.
    Ikeguchi M; Teeter LD; Eckersberg T; Ganapathi R; Kuo MT
    DNA Cell Biol; 1991 Nov; 10(9):639-49. PubMed ID: 1684503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.